Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Factor X-activating activity from Guerin epithelioma.

W Mielicki¹, R Wierzbicki

¹Department of Biochemistry, Institute of Environmental Research and Bioanalysis, Medical Academy, Lódz, Poland.

|January 1, 1988

Summary

Tumor extracts activate factor X, a key coagulation protein, in vitro. This procoagulant activity (PCA) was observed in both primary tumors and metastases, with no significant difference between them.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Occurrence of Podosphaera xanthii Race 2 on Cucumis melo in Brazil.

Plant disease·2019

Same author

Does the addition of oxaliplatin to preoperative chemoradiation benefit cT4 or fixed cT3 rectal cancer treatment? A subgroup analysis from a prospective study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016

Same author

Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Same author

YMn2Hx and RMn(2-y)Fe(y)H6 (R = Y, Er) studied by Raman, infrared and inelastic neutron scattering spectroscopies.

Faraday discussions·2012

Same author

Structural and magnetic properties of DyMn(2)D(6) synthesized under high deuterium pressure.

Journal of physics. Condensed matter : an Institute of Physics journal·2011

Same author

Formation of hydrides in (Ti(1-x)Zr(x))Co(2.00) (0 < x < 1) pseudobinary alloys.

Inorganic chemistry·2009

Area of Science:

Oncology
Hematology
Biochemistry

Background:

Procoagulant activity (PCA) in tumors can contribute to thrombosis.
Understanding the source and nature of PCA in cancer is crucial for therapeutic development.

Purpose of the Study:

To investigate the procoagulant activity (PCA) in experimental Guerin epithelioma primary tumors and metastases.
To characterize the biochemical properties of the PCA observed in tumor extracts.

Main Methods:

Extraction of tissues from primary tumors and metastases of Guerin epithelioma in Wistar rats.
Assay of procoagulant activity by measuring factor X activation using chromogenic substrate S-2222.
Inhibition studies using phenylmethylsulfonyl fluoride (PMSF), mercuric chloride, p-chloromercuric benzoate (p-CMB), and iodoacetic acid (IAA).

Main Results:

Tumor extracts from both primary tumors and metastases demonstrated procoagulant activity (PCA) by activating factor X in vitro.
The observed PCA was independent of factor VII.
Inhibition studies indicated the involvement of serine proteases and sulfhydryl groups in the PCA.

Conclusions:

Guerin epithelioma primary tumors and metastases exhibit similar procoagulant activity (PCA).
The PCA is likely mediated by a metalloproteinase or serine protease and involves sulfhydryl groups.
These findings suggest a potential role for tumor-derived procoagulant factors in cancer-associated thrombosis.

Related Experiment Videos